January 1, 2013World Journal of Cardiovascular DiseasesOpen Access

Diabetic cardiomyopathy—What do we know about it?

View Full Paper

Ask AI

Bookmark

Population

Patients with diabetic cardiomyopathy

Design

Review

Authors

MHMuhammad Asrar ul HaqAllama Iqbal Medical College VMV. MuthaNorthern Hospital NRN. RuddThe University of Melbourne

Discussion

Member takes

Implication

May support glycemic control plus early neurohormonal blockade in diabetic cardiomyopathy; leaves open need for dedicated prospective trials.

Structured PICO

Population

Patients with diabetic cardiomyopathy (defined as myocardial dysfunction in patients with diabetes in the absence of coronary artery disease, hypertension, or other known cardiac disease)

This review highlights that diabetic cardiomyopathy is driven by hyperglycemia and managed primarily through careful glycemic control and early neurohormonal antagonism.

Cite This Study

Haq et al. (2013) studied this question.

synapsesocial.com/papers/6a7fcc134e87c41f45b17506 https://doi.org/10.4236/wjcd.2013.35a005

View Full Paper

Ask AI

Bookmark

Implication

May support glycemic control plus early neurohormonal blockade in diabetic cardiomyopathy; leaves open need for dedicated prospective trials.

Diabetic cardiomyopathy—What do we know about it?

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Diabetic cardiomyopathy—What do we know about it?

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider